Wunderlich Capital Managemnt Increases Holdings in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX)

Wunderlich Capital Managemnt grew its holdings in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) by 5.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,299 shares of the pharmaceutical company’s stock after purchasing an additional 66 shares during […]

Related Keywords

United States ,New Hampshire ,America ,Kristen Ambrose ,Brucei Sachs ,Vertex Pharmaceuticals ,Yd More Investments Ltd ,Quarter For Vertex Pharmaceuticals ,Sandy Spring Bank ,Exchange Commission ,Steward Financial Group ,Vertex Pharmaceuticals Company Profile ,Vertex Pharmaceuticals Trading ,News Ratings For Vertex Pharmaceuticals Daily ,Vertex Pharmaceuticals Incorporated ,Freedom Wealth Alliance ,Securities Exchange Commission ,Wunderlich Capital Managemnt ,Free Report ,Capital Managemnt ,Spring Bank ,Investments Ltd ,Financial Group ,Hampshire Trust ,Director Bruce ,Pharmaceuticals Incorporated ,Visit Holdingschannel ,Vertex Pharmaceuticals Daily ,Nasdaq Vrtx ,Vrtx ,Medical ,92532f10 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,